•
Sep 30, 2021

Prelude Therapeutics Q3 2021 Earnings Report

EPS
-$0.66
Previous year: -$5.25
-87.4%
Cash and Equivalents
$61.4M
Free Cash Flow
-$22.4M
Total Assets
$331M

Prelude Therapeutics

Prelude Therapeutics